Evidence-based treatments for STEMI: are we doing enough?

Affiliations

Editorial

Stefan K James et al. Lancet. 2013.

. 2013 Aug 17;382(9892):576-9.

doi: 10.1016/S0140-6736(13)61716-X.

¹ Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University Hospita, 751 85 Uppsala, Sweden. stefan.james@ucr.uu.se

No abstract available

Comment on

Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention?
Gershlick AH, Banning AP, Myat A, Verheugt FW, Gersh BJ. Gershlick AH, et al. Lancet. 2013 Aug 17;382(9892):624-32. doi: 10.1016/S0140-6736(13)61454-3. Lancet. 2013. PMID: 23953386 Review.
What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?
Curzen N, Gurbel PA, Myat A, Bhatt DL, Redwood SR. Curzen N, et al. Lancet. 2013 Aug 17;382(9892):633-43. doi: 10.1016/S0140-6736(13)61453-1. Lancet. 2013. PMID: 23953387 Review.
Future treatment strategies in ST-segment elevation myocardial infarction.
Windecker S, Bax JJ, Myat A, Stone GW, Marber MS. Windecker S, et al. Lancet. 2013 Aug 17;382(9892):644-57. doi: 10.1016/S0140-6736(13)61452-X. Lancet. 2013. PMID: 23953388 Review.